Moreover, intravenous injection of CVA21-ICAM1-DAF was combined with intraperitoneal injection of doxorubicin hydrochloride resulted in significantly enhanced tumor regression compared to either viral or drug delivery alone in mice with MDA-MB-231 xenografts [120]. This evidence concerns the gene ICAM1 and neoplasm.